Nom du produit:6-Hydroxy-2-pyridinecarboxylic acid

IUPAC Name:6-oxo-1,6-dihydropyridine-2-carboxylic acid

CAS:19621-92-2
Formule moléculaire:C6H5NO3
Pureté:97%
Numéro de catalogue:CM170741
Poids moléculaire:139.11

Unité d'emballage Stock disponible Prix($) Quantité
CM170741-100g in stock ǵȎǵ
CM170741-500g 1-2 Weeks Ţʼnʼn

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:19621-92-2
Formule moléculaire:C6H5NO3
Point de fusion:-
Code SMILES:O=C(C1=CC=CC(N1)=O)O
Densité:
Numéro de catalogue:CM170741
Poids moléculaire:139.11
Point d'ébullition:436°C at 760 mmHg
N° Mdl:MFCD00192220
Stockage:Store at room temperature.

Category Infos

Pyridines
Pyridine is a six-membered heterocyclic compound containing one nitrogen heteroatom. Pyridine and piperidine are the most frequently occurring heterocyclic building blocks in drug molecules. According to incomplete statistics, there are currently more than 180 drugs containing pyridine or piperidine structure that have been marketed, nearly 1/5 of the drugs approved for marketing in recent years contain these two structures.
Pyridine | C5H5N | Pyridine Supplier/Distributor/Manufacturer - Chemenu
Pyridine,Pyridine Wholesale,Pyridine for Sale,Pyridine Supplier,Pyridine Distributor,Pyridine Manufacturer
Pyridine is a basic heterocyclic organic compound with the chemical formula C5H5N. It is structurally related to benzene, with one methine group (=CH−) replaced by a nitrogen atom. It is a highly flammable, weakly alkaline, water-miscible liquid with a distinctive, unpleasant fish-like smell.

Column Infos

PF-06648671
The Journal of Medicinal Chemistry recently publishes an article titled, “Discovery of Clinical Candidate PF-06648671: A Potent γ-Secretase Modulator for the Treatment of Alzheimer’s Disease”. Amyloid β-peptide (Aβ) accumulation is one of the key hallmarks of Alzheimer’s disease (AD). γ-secretase cleaves the amyloid precursor protein (APP) into pathologically relevant Aβs, and has been widely studied as a potential target for the treatment of AD.
Pfizer‘s PF-06648671 is a Gamma secretase modulator (GSM) targeting APP processing. It is found to have excellent central exposure in human and robust reduction of amyloidogenic forms (Aβ42) in cerebrospinal fluid (CSF).